The global market for Lumbosacral Radicular Pain Treatment was estimated to be worth US$ 857 million in 2023 and is forecast to a readjusted size of US$ 1206.1 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030

Lumbosacral Radicular Pain Treatment - Market

Lumbosacral radicular pain is a type of pain that originates from the lower back and radiates down the leg, typically caused by compression or irritation of the spinal nerves.

Lumbosacral radicular pain is a type of pain that originates from the lower back and radiates down the leg, typically caused by compression or irritation of the spinal nerves. The treatment of lumbosacral radicular pain typically involves a combination of pharmacological and non-pharmacological interventions.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Lumbosacral Radicular Pain Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Lumbosacral Radicular Pain Treatment by region & country, by Type, and by Application.

The Lumbosacral Radicular Pain Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lumbosacral Radicular Pain Treatment.

Market Segmentation

Scope of Lumbosacral Radicular Pain Treatment - Market Report

Report Metric	Details
Report Name	Lumbosacral Radicular Pain Treatment - Market
Forecasted market size in 2030	US$ 1206.1 million
CAGR	5.0%
Forecasted years	2024 - 2030
Segment by Type:	Oral Topical
Segment by Application	Hospital Pharmacy Retail Pharmacy Online Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Competition Deep Dive, Semnur Pharmaceuticals, Inc., Eliem Therapeutics, Forest Laboratories, Medtronic Spinal and Biologics, Teva Pharmaceutical, 3M Company, Ultradent Products Inc., Nobel Biocare Holdings AG, Eli Lilly & Company
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Lumbosacral Radicular Pain Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Lumbosacral Radicular Pain Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Lumbosacral Radicular Pain Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Lumbosacral Radicular Pain Treatment - Market size in 2030?

Ans: The Lumbosacral Radicular Pain Treatment - Market size in 2030 will be US$ 1206.1 million.

Who are the main players in the Lumbosacral Radicular Pain Treatment - Market report?

Ans: The main players in the Lumbosacral Radicular Pain Treatment - Market are Competition Deep Dive, Semnur Pharmaceuticals, Inc., Eliem Therapeutics, Forest Laboratories, Medtronic Spinal and Biologics, Teva Pharmaceutical, 3M Company, Ultradent Products Inc., Nobel Biocare Holdings AG, Eli Lilly & Company

What are the Application segmentation covered in the Lumbosacral Radicular Pain Treatment - Market report?

Ans: The Applications covered in the Lumbosacral Radicular Pain Treatment - Market report are Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

What are the Type segmentation covered in the Lumbosacral Radicular Pain Treatment - Market report?

Ans: The Types covered in the Lumbosacral Radicular Pain Treatment - Market report are Oral, Topical

1 Market Overview

1.1 Lumbosacral Radicular Pain Treatment Product Introduction

1.2 Global Lumbosacral Radicular Pain Treatment Market Size Forecast

1.3 Lumbosacral Radicular Pain Treatment Market Trends & Drivers

1.3.1 Lumbosacral Radicular Pain Treatment Industry Trends

1.3.2 Lumbosacral Radicular Pain Treatment Market Drivers & Opportunity

1.3.3 Lumbosacral Radicular Pain Treatment Market Challenges

1.3.4 Lumbosacral Radicular Pain Treatment Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Lumbosacral Radicular Pain Treatment Players Revenue Ranking (2023)

2.2 Global Lumbosacral Radicular Pain Treatment Revenue by Company (2019-2024)

2.3 Key Companies Lumbosacral Radicular Pain Treatment Manufacturing Base Distribution and Headquarters

2.4 Key Companies Lumbosacral Radicular Pain Treatment Product Offered

2.5 Key Companies Time to Begin Mass Production of Lumbosacral Radicular Pain Treatment

2.6 Lumbosacral Radicular Pain Treatment Market Competitive Analysis

2.6.1 Lumbosacral Radicular Pain Treatment Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Lumbosacral Radicular Pain Treatment Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lumbosacral Radicular Pain Treatment as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Oral

3.1.2 Topical

3.2 Global Lumbosacral Radicular Pain Treatment Sales Value by Type

3.2.1 Global Lumbosacral Radicular Pain Treatment Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Lumbosacral Radicular Pain Treatment Sales Value, by Type (2019-2030)

3.2.3 Global Lumbosacral Radicular Pain Treatment Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital Pharmacy

4.1.2 Retail Pharmacy

4.1.3 Online Pharmacy

4.2 Global Lumbosacral Radicular Pain Treatment Sales Value by Application

4.2.1 Global Lumbosacral Radicular Pain Treatment Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Lumbosacral Radicular Pain Treatment Sales Value, by Application (2019-2030)

4.2.3 Global Lumbosacral Radicular Pain Treatment Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Lumbosacral Radicular Pain Treatment Sales Value by Region

5.1.1 Global Lumbosacral Radicular Pain Treatment Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Lumbosacral Radicular Pain Treatment Sales Value by Region (2019-2024)

5.1.3 Global Lumbosacral Radicular Pain Treatment Sales Value by Region (2025-2030)

5.1.4 Global Lumbosacral Radicular Pain Treatment Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Lumbosacral Radicular Pain Treatment Sales Value, 2019-2030

5.2.2 North America Lumbosacral Radicular Pain Treatment Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Lumbosacral Radicular Pain Treatment Sales Value, 2019-2030

5.3.2 Europe Lumbosacral Radicular Pain Treatment Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Lumbosacral Radicular Pain Treatment Sales Value, 2019-2030

5.4.2 Asia Pacific Lumbosacral Radicular Pain Treatment Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Lumbosacral Radicular Pain Treatment Sales Value, 2019-2030

5.5.2 South America Lumbosacral Radicular Pain Treatment Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Lumbosacral Radicular Pain Treatment Sales Value, 2019-2030

5.6.2 Middle East & Africa Lumbosacral Radicular Pain Treatment Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Lumbosacral Radicular Pain Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Lumbosacral Radicular Pain Treatment Sales Value

6.3 United States

6.3.1 United States Lumbosacral Radicular Pain Treatment Sales Value, 2019-2030

6.3.2 United States Lumbosacral Radicular Pain Treatment Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Lumbosacral Radicular Pain Treatment Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Lumbosacral Radicular Pain Treatment Sales Value, 2019-2030

6.4.2 Europe Lumbosacral Radicular Pain Treatment Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Lumbosacral Radicular Pain Treatment Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Lumbosacral Radicular Pain Treatment Sales Value, 2019-2030

6.5.2 China Lumbosacral Radicular Pain Treatment Sales Value by Type (%), 2023 VS 2030

6.5.3 China Lumbosacral Radicular Pain Treatment Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Lumbosacral Radicular Pain Treatment Sales Value, 2019-2030

6.6.2 Japan Lumbosacral Radicular Pain Treatment Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Lumbosacral Radicular Pain Treatment Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Lumbosacral Radicular Pain Treatment Sales Value, 2019-2030

6.7.2 South Korea Lumbosacral Radicular Pain Treatment Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Lumbosacral Radicular Pain Treatment Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Lumbosacral Radicular Pain Treatment Sales Value, 2019-2030

6.8.2 Southeast Asia Lumbosacral Radicular Pain Treatment Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Lumbosacral Radicular Pain Treatment Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Lumbosacral Radicular Pain Treatment Sales Value, 2019-2030

6.9.2 India Lumbosacral Radicular Pain Treatment Sales Value by Type (%), 2023 VS 2030

6.9.3 India Lumbosacral Radicular Pain Treatment Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Competition Deep Dive

7.1.1 Competition Deep Dive Profile

7.1.2 Competition Deep Dive Main Business

7.1.3 Competition Deep Dive Lumbosacral Radicular Pain Treatment Products, Services and Solutions

7.1.4 Competition Deep Dive Lumbosacral Radicular Pain Treatment Revenue (US$ Million) & (2019-2024)

7.1.5 Competition Deep Dive Recent Developments

7.2 Semnur Pharmaceuticals, Inc.

7.2.1 Semnur Pharmaceuticals, Inc. Profile

7.2.2 Semnur Pharmaceuticals, Inc. Main Business

7.2.3 Semnur Pharmaceuticals, Inc. Lumbosacral Radicular Pain Treatment Products, Services and Solutions

7.2.4 Semnur Pharmaceuticals, Inc. Lumbosacral Radicular Pain Treatment Revenue (US$ Million) & (2019-2024)

7.2.5 Semnur Pharmaceuticals, Inc. Recent Developments

7.3 Eliem Therapeutics

7.3.1 Eliem Therapeutics Profile

7.3.2 Eliem Therapeutics Main Business

7.3.3 Eliem Therapeutics Lumbosacral Radicular Pain Treatment Products, Services and Solutions

7.3.4 Eliem Therapeutics Lumbosacral Radicular Pain Treatment Revenue (US$ Million) & (2019-2024)

7.3.5 Forest Laboratories Recent Developments

7.4 Forest Laboratories

7.4.1 Forest Laboratories Profile

7.4.2 Forest Laboratories Main Business

7.4.3 Forest Laboratories Lumbosacral Radicular Pain Treatment Products, Services and Solutions

7.4.4 Forest Laboratories Lumbosacral Radicular Pain Treatment Revenue (US$ Million) & (2019-2024)

7.4.5 Forest Laboratories Recent Developments

7.5 Medtronic Spinal and Biologics

7.5.1 Medtronic Spinal and Biologics Profile

7.5.2 Medtronic Spinal and Biologics Main Business

7.5.3 Medtronic Spinal and Biologics Lumbosacral Radicular Pain Treatment Products, Services and Solutions

7.5.4 Medtronic Spinal and Biologics Lumbosacral Radicular Pain Treatment Revenue (US$ Million) & (2019-2024)

7.5.5 Medtronic Spinal and Biologics Recent Developments

7.6 Teva Pharmaceutical

7.6.1 Teva Pharmaceutical Profile

7.6.2 Teva Pharmaceutical Main Business

7.6.3 Teva Pharmaceutical Lumbosacral Radicular Pain Treatment Products, Services and Solutions

7.6.4 Teva Pharmaceutical Lumbosacral Radicular Pain Treatment Revenue (US$ Million) & (2019-2024)

7.6.5 Teva Pharmaceutical Recent Developments

7.7 3M Company

7.7.1 3M Company Profile

7.7.2 3M Company Main Business

7.7.3 3M Company Lumbosacral Radicular Pain Treatment Products, Services and Solutions

7.7.4 3M Company Lumbosacral Radicular Pain Treatment Revenue (US$ Million) & (2019-2024)

7.7.5 3M Company Recent Developments

7.8 Ultradent Products Inc.

7.8.1 Ultradent Products Inc. Profile

7.8.2 Ultradent Products Inc. Main Business

7.8.3 Ultradent Products Inc. Lumbosacral Radicular Pain Treatment Products, Services and Solutions

7.8.4 Ultradent Products Inc. Lumbosacral Radicular Pain Treatment Revenue (US$ Million) & (2019-2024)

7.8.5 Ultradent Products Inc. Recent Developments

7.9 Nobel Biocare Holdings AG

7.9.1 Nobel Biocare Holdings AG Profile

7.9.2 Nobel Biocare Holdings AG Main Business

7.9.3 Nobel Biocare Holdings AG Lumbosacral Radicular Pain Treatment Products, Services and Solutions

7.9.4 Nobel Biocare Holdings AG Lumbosacral Radicular Pain Treatment Revenue (US$ Million) & (2019-2024)

7.9.5 Nobel Biocare Holdings AG Recent Developments

7.10 Eli Lilly & Company

7.10.1 Eli Lilly & Company Profile

7.10.2 Eli Lilly & Company Main Business

7.10.3 Eli Lilly & Company Lumbosacral Radicular Pain Treatment Products, Services and Solutions

7.10.4 Eli Lilly & Company Lumbosacral Radicular Pain Treatment Revenue (US$ Million) & (2019-2024)

7.10.5 Eli Lilly & Company Recent Developments

8 Industry Chain Analysis

8.1 Lumbosacral Radicular Pain Treatment Industrial Chain

8.2 Lumbosacral Radicular Pain Treatment Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Lumbosacral Radicular Pain Treatment Sales Model

8.5.2 Sales Channel

8.5.3 Lumbosacral Radicular Pain Treatment Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Forest Laboratories

Teva Pharmaceutical

3M Company

Ultradent Products, Inc.

Nobel Biocare Holdings AG

Eli lilly company

Semnur Pharmaceuticals, Inc.

Eliem Therapeutics

Medtronic Spinal and Biologics

List of Tables

Table 1. Lumbosacral Radicular Pain Treatment Market Trends

Table 2. Lumbosacral Radicular Pain Treatment Market Drivers & Opportunity

Table 3. Lumbosacral Radicular Pain Treatment Market Challenges

Table 4. Lumbosacral Radicular Pain Treatment Market Restraints

Table 5. Global Lumbosacral Radicular Pain Treatment Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Lumbosacral Radicular Pain Treatment Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Lumbosacral Radicular Pain Treatment Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Lumbosacral Radicular Pain Treatment Product Type

Table 9. Key Companies Time to Begin Mass Production of Lumbosacral Radicular Pain Treatment

Table 10. Global Lumbosacral Radicular Pain Treatment Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lumbosacral Radicular Pain Treatment as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Lumbosacral Radicular Pain Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Lumbosacral Radicular Pain Treatment Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Lumbosacral Radicular Pain Treatment Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Lumbosacral Radicular Pain Treatment Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Lumbosacral Radicular Pain Treatment Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Lumbosacral Radicular Pain Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Lumbosacral Radicular Pain Treatment Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Lumbosacral Radicular Pain Treatment Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Lumbosacral Radicular Pain Treatment Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Lumbosacral Radicular Pain Treatment Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Lumbosacral Radicular Pain Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Lumbosacral Radicular Pain Treatment Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Lumbosacral Radicular Pain Treatment Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Lumbosacral Radicular Pain Treatment Sales Value by Region (2019-2024) & (%)

Table 27. Global Lumbosacral Radicular Pain Treatment Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Lumbosacral Radicular Pain Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Lumbosacral Radicular Pain Treatment Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Lumbosacral Radicular Pain Treatment Sales Value, (2025-2030) & (US$ Million)

Table 31. Competition Deep Dive Basic Information List

Table 32. Competition Deep Dive Description and Business Overview

Table 33. Competition Deep Dive Lumbosacral Radicular Pain Treatment Products, Services and Solutions

Table 34. Revenue (US$ Million) in Lumbosacral Radicular Pain Treatment Business of Competition Deep Dive (2019-2024)

Table 35. Competition Deep Dive Recent Developments

Table 36. Semnur Pharmaceuticals, Inc. Basic Information List

Table 37. Semnur Pharmaceuticals, Inc. Description and Business Overview

Table 38. Semnur Pharmaceuticals, Inc. Lumbosacral Radicular Pain Treatment Products, Services and Solutions

Table 39. Revenue (US$ Million) in Lumbosacral Radicular Pain Treatment Business of Semnur Pharmaceuticals, Inc. (2019-2024)

Table 40. Semnur Pharmaceuticals, Inc. Recent Developments

Table 41. Eliem Therapeutics Basic Information List

Table 42. Eliem Therapeutics Description and Business Overview

Table 43. Eliem Therapeutics Lumbosacral Radicular Pain Treatment Products, Services and Solutions

Table 44. Revenue (US$ Million) in Lumbosacral Radicular Pain Treatment Business of Eliem Therapeutics (2019-2024)

Table 45. Eliem Therapeutics Recent Developments

Table 46. Forest Laboratories Basic Information List

Table 47. Forest Laboratories Description and Business Overview

Table 48. Forest Laboratories Lumbosacral Radicular Pain Treatment Products, Services and Solutions

Table 49. Revenue (US$ Million) in Lumbosacral Radicular Pain Treatment Business of Forest Laboratories (2019-2024)

Table 50. Forest Laboratories Recent Developments

Table 51. Medtronic Spinal and Biologics Basic Information List

Table 52. Medtronic Spinal and Biologics Description and Business Overview

Table 53. Medtronic Spinal and Biologics Lumbosacral Radicular Pain Treatment Products, Services and Solutions

Table 54. Revenue (US$ Million) in Lumbosacral Radicular Pain Treatment Business of Medtronic Spinal and Biologics (2019-2024)

Table 55. Medtronic Spinal and Biologics Recent Developments

Table 56. Teva Pharmaceutical Basic Information List

Table 57. Teva Pharmaceutical Description and Business Overview

Table 58. Teva Pharmaceutical Lumbosacral Radicular Pain Treatment Products, Services and Solutions

Table 59. Revenue (US$ Million) in Lumbosacral Radicular Pain Treatment Business of Teva Pharmaceutical (2019-2024)

Table 60. Teva Pharmaceutical Recent Developments

Table 61. 3M Company Basic Information List

Table 62. 3M Company Description and Business Overview

Table 63. 3M Company Lumbosacral Radicular Pain Treatment Products, Services and Solutions

Table 64. Revenue (US$ Million) in Lumbosacral Radicular Pain Treatment Business of 3M Company (2019-2024)

Table 65. 3M Company Recent Developments

Table 66. Ultradent Products Inc. Basic Information List

Table 67. Ultradent Products Inc. Description and Business Overview

Table 68. Ultradent Products Inc. Lumbosacral Radicular Pain Treatment Products, Services and Solutions

Table 69. Revenue (US$ Million) in Lumbosacral Radicular Pain Treatment Business of Ultradent Products Inc. (2019-2024)

Table 70. Ultradent Products Inc. Recent Developments

Table 71. Nobel Biocare Holdings AG Basic Information List

Table 72. Nobel Biocare Holdings AG Description and Business Overview

Table 73. Nobel Biocare Holdings AG Lumbosacral Radicular Pain Treatment Products, Services and Solutions

Table 74. Revenue (US$ Million) in Lumbosacral Radicular Pain Treatment Business of Nobel Biocare Holdings AG (2019-2024)

Table 75. Nobel Biocare Holdings AG Recent Developments

Table 76. Eli Lilly & Company Basic Information List

Table 77. Eli Lilly & Company Description and Business Overview

Table 78. Eli Lilly & Company Lumbosacral Radicular Pain Treatment Products, Services and Solutions

Table 79. Revenue (US$ Million) in Lumbosacral Radicular Pain Treatment Business of Eli Lilly & Company (2019-2024)

Table 80. Eli Lilly & Company Recent Developments

Table 81. Key Raw Materials Lists

Table 82. Raw Materials Key Suppliers Lists

Table 83. Lumbosacral Radicular Pain Treatment Downstream Customers

Table 84. Lumbosacral Radicular Pain Treatment Distributors List

Table 85. Research Programs/Design for This Report

Table 86. Key Data Information from Secondary Sources

Table 87. Key Data Information from Primary Sources

Table 88. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Lumbosacral Radicular Pain Treatment Product Picture

Figure 2. Global Lumbosacral Radicular Pain Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Lumbosacral Radicular Pain Treatment Sales Value (2019-2030) & (US$ Million)

Figure 4. Lumbosacral Radicular Pain Treatment Report Years Considered

Figure 5. Global Lumbosacral Radicular Pain Treatment Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Lumbosacral Radicular Pain Treatment Revenue in 2023

Figure 7. Lumbosacral Radicular Pain Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Oral Picture

Figure 9. Topical Picture

Figure 10. Global Lumbosacral Radicular Pain Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 11. Global Lumbosacral Radicular Pain Treatment Sales Value Market Share by Type, 2023 & 2030

Figure 12. Product Picture of Hospital Pharmacy

Figure 13. Product Picture of Retail Pharmacy

Figure 14. Product Picture of Online Pharmacy

Figure 15. Global Lumbosacral Radicular Pain Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Lumbosacral Radicular Pain Treatment Sales Value Market Share by Application, 2023 & 2030

Figure 17. North America Lumbosacral Radicular Pain Treatment Sales Value (2019-2030) & (US$ Million)

Figure 18. North America Lumbosacral Radicular Pain Treatment Sales Value by Country (%), 2023 VS 2030

Figure 19. Europe Lumbosacral Radicular Pain Treatment Sales Value (2019-2030) & (US$ Million)

Figure 20. Europe Lumbosacral Radicular Pain Treatment Sales Value by Country (%), 2023 VS 2030

Figure 21. Asia Pacific Lumbosacral Radicular Pain Treatment Sales Value (2019-2030) & (US$ Million)

Figure 22. Asia Pacific Lumbosacral Radicular Pain Treatment Sales Value by Country (%), 2023 VS 2030

Figure 23. South America Lumbosacral Radicular Pain Treatment Sales Value (2019-2030) & (US$ Million)

Figure 24. South America Lumbosacral Radicular Pain Treatment Sales Value by Country (%), 2023 VS 2030

Figure 25. Middle East & Africa Lumbosacral Radicular Pain Treatment Sales Value (2019-2030) & (US$ Million)

Figure 26. Middle East & Africa Lumbosacral Radicular Pain Treatment Sales Value by Country (%), 2023 VS 2030

Figure 27. Key Countries/Regions Lumbosacral Radicular Pain Treatment Sales Value (%), (2019-2030)

Figure 28. United States Lumbosacral Radicular Pain Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 29. United States Lumbosacral Radicular Pain Treatment Sales Value by Type (%), 2023 VS 2030

Figure 30. United States Lumbosacral Radicular Pain Treatment Sales Value by Application (%), 2023 VS 2030

Figure 31. Europe Lumbosacral Radicular Pain Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 32. Europe Lumbosacral Radicular Pain Treatment Sales Value by Type (%), 2023 VS 2030

Figure 33. Europe Lumbosacral Radicular Pain Treatment Sales Value by Application (%), 2023 VS 2030

Figure 34. China Lumbosacral Radicular Pain Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 35. China Lumbosacral Radicular Pain Treatment Sales Value by Type (%), 2023 VS 2030

Figure 36. China Lumbosacral Radicular Pain Treatment Sales Value by Application (%), 2023 VS 2030

Figure 37. Japan Lumbosacral Radicular Pain Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 38. Japan Lumbosacral Radicular Pain Treatment Sales Value by Type (%), 2023 VS 2030

Figure 39. Japan Lumbosacral Radicular Pain Treatment Sales Value by Application (%), 2023 VS 2030

Figure 40. South Korea Lumbosacral Radicular Pain Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 41. South Korea Lumbosacral Radicular Pain Treatment Sales Value by Type (%), 2023 VS 2030

Figure 42. South Korea Lumbosacral Radicular Pain Treatment Sales Value by Application (%), 2023 VS 2030

Figure 43. Southeast Asia Lumbosacral Radicular Pain Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Lumbosacral Radicular Pain Treatment Sales Value by Type (%), 2023 VS 2030

Figure 45. Southeast Asia Lumbosacral Radicular Pain Treatment Sales Value by Application (%), 2023 VS 2030

Figure 46. India Lumbosacral Radicular Pain Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 47. India Lumbosacral Radicular Pain Treatment Sales Value by Type (%), 2023 VS 2030

Figure 48. India Lumbosacral Radicular Pain Treatment Sales Value by Application (%), 2023 VS 2030

Figure 49. Lumbosacral Radicular Pain Treatment Industrial Chain

Figure 50. Lumbosacral Radicular Pain Treatment Manufacturing Cost Structure

Figure 51. Channels of Distribution (Direct Sales, and Distribution)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Acute Pain Management Services Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-33T5613

Sat Jul 20 00:00:00 UTC 2024

Add to Cart

Global Conventional and Alternative Pain Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-25I8342

Fri Jul 19 00:00:00 UTC 2024

Add to Cart

Global Loxoprofen Sodium Gel Patch Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-26D17225

Fri Jun 21 00:00:00 UTC 2024

Add to Cart

Global Flurbiprofen Gel Patch Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-32J17410

Fri Jun 21 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions